Board of Directors
Daniel Lifveredson
Born: 1976
Education: Master of Science in Industrial Engineering and Management, Chalmers University of Technology in Gothenburg
Other assignments: CEO and owner of Excore AB
Work experience: Worked with Excore as a base since 1998. Excore is active in advising corporate transactions in the segment of medium-sized companies. Long experience in international business. In addition to Excore, Daniel Lifveredson is involved as a partner in a number of businesses.
Holdings: 28,029,909 shares
Independent in relation to LIDDS AB (publ), its management and the principal shareholders
Torbjörn Browall
Born: 1962
Education: Civilekonomexamen från Handelshögskolan i Göteborg
Other Assignments: Board Member in Immobilien Österreich AB, Immobilien Akustik AB, Off Piste GmbH and Persula AB and deputy board member in Blekinghus AB, Browall Event AB and Aftertainment AB.
Work Experience: Leading roles within SKF, Gränges, Gunnebo, Volvo and Gnosjögruppen. He has during the last 15 years been active in entrepreneurial companies within different sectors.
Holdings: 4,750,000 shares
He is independent in relation to LIDDS AB and its management and to major shareholders in the company.
Lars-Inge Sjöqvist
Born: 1958
Education: Civil engineer from Chalmers University, Gothenburg.
Other Assignments: CEO of Actionstep AB and Board member in SHT Smart High Tech AB
Work Experience CEO of Actionstep AB and more than 30 years experience from business and product development and management roles such as CEO of Gapwaves AB (publ), Vice President and CEO of Semcon AB (publ) and Chairman of the Board of Trebax AB and Kildal Antenn AB.
Holdings: 988,470 shares
He is independent in relation to LIDDS AB and its management and to major shareholders in the company.
Stefan Rehnmark
Born: 1956
Education: PhD in Physiology from the Wenner-Gren Institute, Stockholm University
Other assignments: CSO Gabather AB, deputy Board member and CEO of PEthmark AB and deputy Board member of MRW Discovery AB.
Work Experience: Researcher at Harvard Medical School and University of California Los Angeles USA. Co-founder of Axcentua Pharmaceuticals and Noviga Research AB.
Holdings: 6,632,971 shares
Independent in relation to LIDDS AB (publ), its management and the principal shareholders.